Search
Enovis Corp
ENOVAdd to Watchlist
24.590USD
-0.310-1.24%
Close 08-28 16:00（ET）
1.42BMarket Cap
LossP/E TTM
More Details of Enovis Corp Company
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Enovis Corp Profile
Ticker SymbolENOV
Company nameEnovis Corp
IPO dateMay 08, 2008
CEOMcdonald (Damien)
Number of employees7367
Security typeOrdinary Share
Fiscal year-endMay 08
Address2711 Centerville Road
CityWILMINGTON
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code19808
Phone13022529160
Websitehttps://www.enovis.com/
Ticker SymbolENOV
IPO dateMay 08, 2008
CEOMcdonald (Damien)
Company Executives of Enovis Corp
Name
Name/Position
Position
Shareholding
Change
Mr. Daniel Alexis Pryor
Mr. Daniel Alexis Pryor
Executive Vice President - Strategy and Business Development
Executive Vice President - Strategy and Business Development
127.55K
+10.74%
Mr. Oliver Engert
Mr. Oliver Engert
Chief Administrative Officer
Chief Administrative Officer
52.84K
+7.95%
Mr. Oliver Engert
Mr. Oliver Engert
Chief Administrative Officer
Chief Administrative Officer
52.84K
+7.95%
Ms. Sharon L. Wienbar
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
41.95K
+22.28%
Ms. Sharon L. Wienbar
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
41.95K
+22.28%
Mr. Rajiv Vinnakota
Mr. Rajiv Vinnakota
Independent Director
Independent Director
27.46K
+34.03%
Mr. Rajiv Vinnakota
Mr. Rajiv Vinnakota
Independent Director
Independent Director
27.46K
+34.03%
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Independent Director
Independent Director
22.35K
+41.81%
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Independent Director
Independent Director
22.35K
+41.81%
Mr. Louis Vogt
Mr. Louis Vogt
Group President - Reconstructive
Group President - Reconstructive
20.51K
-73.10%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Daniel Alexis Pryor
Mr. Daniel Alexis Pryor
Executive Vice President - Strategy and Business Development
Executive Vice President - Strategy and Business Development
127.55K
+10.74%
Mr. Oliver Engert
Mr. Oliver Engert
Chief Administrative Officer
Chief Administrative Officer
52.84K
+7.95%
Mr. Oliver Engert
Mr. Oliver Engert
Chief Administrative Officer
Chief Administrative Officer
52.84K
+7.95%
Ms. Sharon L. Wienbar
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
41.95K
+22.28%
Ms. Sharon L. Wienbar
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
41.95K
+22.28%
Mr. Rajiv Vinnakota
Mr. Rajiv Vinnakota
Independent Director
Independent Director
27.46K
+34.03%
FAQs
Who are the top five shareholders of Enovis Corp?
The top five shareholders of Enovis Corp are: Mr. Daniel Alexis Pryor
How many institutions hold shares of Enovis Corp (ENOV)?
As of 2026Q1, 652 institutions hold shares of Enovis Corp, with a combined market value of approximately 68.97M, accounting for 119.81% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -6763998.00.
What is the biggest source of revenue for Enovis Corp?
In 2026Q1, the International Reconstructive business generated the highest revenue for Enovis Corp, amounting to 156.71M and accounting for 26.89% of total revenue.